Pelvic Floor Symptoms Across Menopausel Stages

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age40-65
SponsorBezmialem Vakif University

About this trial

The menopausal transition is associated with substantial hormonal alterations that may adversely affect lower urinary tract function, bowel function, and sexual health. Although these symptoms are common, few studies have comprehensively evaluated all three pelvic floor compartments across different menopausal stages.

The aim of this study is to compare lower urinary tract symptoms, bowel symptoms, and female sexual function among women in the perimenopausal, early postmenopausal, and late postmenopausal stages. In addition, the relationship between menopausal stage and symptom severity will be investigated.

Eligibility criteria

Qualifiers

Female

Age 40-65 years

Intact uterus and at least one ovary

Perimenopause or postmenopause according to STRAW+10 criteria

Disqualifiers

Hormone replacement therapy within the previous 6 months

Oral contraceptive use

Antipsychotic medication use

Previous pelvic surgery

Trial design

Treatments tested in this trial

  • Assessment for Lower Urinary Tract Symptoms
  • Assessment for Bowel Symptoms
  • Constipation Severity Assessment
  • Sexual Function Assessment

Treatment groups

180 Participants
are divided into 3 treatment groups

Sponsors and collaborators